Article Sidebar

PDF
Date Published: 12/06/2021
Abstract Views: 318
Views PDF: 204
DOI: https://doi.org/10.51298/vmj.v500i2.351
Issue
Vol. 500 No. 2 (2021)
Section
Các bài báo
How to Cite
Thị Hồng Thanh, L. ., & Văn Em, Đặng . (2021). EVALUATED THE CONCENTRATION OF CYTOKINES IN SEVERE PSORIASIS VULGARIS WAS TREATED BY CYCLOSPORINE A. Vietnam Medical Journal, 500(2). https://doi.org/10.51298/vmj.v500i2.351

EVALUATED THE CONCENTRATION OF CYTOKINES IN SEVERE PSORIASIS VULGARIS WAS TREATED BY CYCLOSPORINE A

Lê Thị Hồng Thanh, Đặng Văn Em

Main Article Content

Abstract

Objective: To evaluated the concentration of cytokines: IL-2, IL-6, IL-8, IL-10, IL-12, IL-17, INF-, TNF-α in patients with severe psoriasis vulgaris was treated by Cyclosporine A. Subject and method: 35 out-patients with severe psoriasis vulgaris had treated at National Dermatology Hospital from October2016 to October 2019were quantified concentration of cytokines IL-2, IL-6, IL -8, IL-10, IL-12, IL-17, INF-, TNF-α in serum before and after treatment with Cyclosporine A (daily dose 2,5-3mg/kg/day) in 10 weeks. Result: The concentration of cytokines IL-2, IL-6, IL-8, IL-10, IL-12, IL-17, TNF-α before and after treatment was not changed that has statistically significant with p>0.05. However, the concentration of INF-after treatment reduced that significantly, with p<0.05. Conclusion: Patients with severe psoriasis vulgaris were treated by Cyclosporine A (daily dose 2,5-3mg/kg/day) have not changed the concentrations of IL-2, IL-6, IL-8, IL-10, IL-12, IL-17, TNF-α after 10 weeks. However, the concentration of INF-has reduced that statisticallysignificantly.

Article Details

Keywords

Severe psoriaisis vulgaris, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17, INF-, TNF-α

References

1. Đặng Văn Em. (2013). Bệnh vảy nến: Sinh bệnh học và chiến lược điều trị. Sách chuyên khảo Nhà xuất bản y học., 236 tr.
2. WHO. (2016). The burden of psoriasis. Global report on psoriasis., Chapter 2.
3. Hawkes. J. E., Chan. T. C., Krueger. J. G. (2017). Psoriasis pathogenesis and the development of novel targeted immune therapies. Journal of Allergy and Clinical Immunology., 140(3): 645-653.
4. Coimbra. S., Figueiredo. A., Castro. E., et al. (2012). The roles of cells and cytokines in the pathogenesis of psoriasis. International journal of dermatology., 51(4): 389-398.
5. Phạm Diễm Thuý., Đặng Văn Em., Lý Tuấn Khải. (2019). Nghiên cứu sự thay đổi nồng độ một số cytokine trước và cytokine trước và sau điều trị bệnh vảy nến thông thường bằng chiếu UVB-311nm kết hợp uống Methotrexate liều thấp. Tạp chí y dược lâm sàng 108., 3.
6. Phan Huy Thục. (2015). Nghiên cứu đặc điểm lâm sàng và mối liên quan giữa nồng độ cytokine với kết quả điều trị bệnh vảy nến thông thường bằng methotrexate. Luận án tiến sỹ y học, Đại học Y hà nội., 129 tr.
7. Haider. A. S., Lowes. M. A., Suárez-Fariñas. M., et al. (2008). Identification of cellular pathways of" type 1," Th17 T cells, and TNF-and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. Journal of immunology., 180(3): 1913.
8. Ikonomidis. I., Papadavid. E., Makavos. G., et al. (2017). Lowering interleukin-12 activity improves myocardial and vascular function compared with tumor necrosis factor-a antagonism or cyclosporine in psoriasis. Circulation: Cardiovascular Imaging., 10(9): 006283.